Floatz logo

25 assets in Huntington Disease

Therapeutic assets addressing Huntington Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Deutetrabenazine
Huntington Disease
Teva Branded Pharmaceutical Products R&D LLCP4BBB (76)
Tominersen
Huntington Disease
Hoffmann-La RocheP3BBB (72)
Pridopidine
Huntington Disease
PrileniaP3BB (69)
MT-5199
Huntington Disease
Neurocrine BiosciencesP3BB (68)
Dalzanemdor
Huntington Disease
Supernus Pharmaceuticals, Inc.P3BB (66)
Bevantolol
Huntington Disease
SOM Innovation Biotech SAP2B (62)
Votoplam
Huntington Disease
Novartis PharmaceuticalsP3B (62)
Metformin
Huntington Disease
Instituto de Investigacion Sanitaria La FeP3B (60)
Mbf-015
Huntington Disease
Medibiofarma S.L.P2B (57)
Nestacell®
Huntington Disease
Azidus BrasilP3B (57)
Sky-0515
Huntington Disease
Skyhawk Therapeutics, Inc.P2/3CCC (55)
Acetylcysteine
Huntington Disease
Western Sydney Local Health DistrictP2CCC (53)
Branaplam
Huntington Disease
Novartis PharmaceuticalsP2CCC (53)
[14c] lpm3770164
Huntington Disease
Luye Pharma Group Ltd.P1CCC (52)
er2001
Huntington Disease
ExoRNA BioscienceP1/2CCC (50)
ab-1001 gene therapy
Huntington Disease
AskBio France, SAS, a subsidiary of AskBio Inc.P1/2CC (45)
Dna (Recombinant Replication-Deficient Adeno-Associated Virus 5 Vector Amt-130 Chicken .Beta.-Actin Promoter Plus Human Huntingtin Mrna-Targeting Microrna Mihtt-Specifying)
Huntington Disease
UniQure Biopharma B.V.P1/2CC (45)
Hnsc-01
Huntington Disease
Leslie ThompsonP1/2CC (45)
Spk-10001
Huntington Disease
Hoffmann-La RocheP1/2CC (45)
vo659
Huntington Disease
Vico Therapeutics B. V.P1/2CC (45)
Aln-Htt02
Huntington Disease
Alnylam PharmaceuticalsP1CC (43)
rg6496
Huntington Disease
Hoffmann-La RocheP1CC (43)
Srp-1005
Huntington Disease
Sarepta Therapeutics, Inc.P1CC (43)
[11C]UCB-J
Huntington Disease
Universitaire Ziekenhuizen KU LeuvenN/AD (30)
[18F]SynVest-1
Huntington Disease
Universitaire Ziekenhuizen KU LeuvenN/AD (30)